Schedule 13G ownership disclosure

APPLIED THERAPEUTICS INC

COMMON STOCK · CUSIP: 03828A101

Event date: 2025-09-30

Filing-level shares
21,403,300
Percent of class
14.9%
  • T. Rowe Price Investment Management, Inc.

    Shares: 21,403,300 · Class: 14.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-25-000543
Form type
SCHEDULE 13G/A
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub